Literature DB >> 12729563

The amino-terminal region of Gli3 antagonizes the Shh response and acts in dorsoventral fate specification in the developing spinal cord.

Néva P Meyer1, Henk Roelink.   

Abstract

A concentration gradient of Shh is thought to pattern the ventral neural tube, and these ventral cell types are absent in shh-/- mice. Based on in vitro and genetic studies, the zinc finger-containing transcription factors Gli 1, 2, and 3 are mediators of the Shh intracellular response. The floorplate and adjacent cell types are absent in gli1-/-;gli2-/- mice, but part of the Shh-/- phenotype in the neural tube is alleviated in the Shh-/-;gli3-/- double mutant. This is consistent with the predicted role of Gli3 as a repressor of the Shh response. Gli3 repressor activity is blocked by Shh. In order to test the role of the repressor form of Gli3 in the neural tube, a truncated version of Gli3 (Gli3R*) was designed to mimic a Pallister Hall allele. Gli3R* acts as a constitutive repressor independent of Shh signaling. Misexpression of Gli3R* in the chick neural tube caused a ventral expansion of class-I, dorsal progenitor proteins and a loss of class-II, ventral progenitor proteins consistent with expected activity as a repressor of the Shh response. Activation of the BMP response is sufficient to maintain gli3 expression in neural plate explants, which might be a mechanism by which BMPs antagonize the Shh response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729563     DOI: 10.1016/s0012-1606(03)00065-4

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  27 in total

Review 1.  Next stop, the twilight zone: hedgehog network regulation of mammary gland development.

Authors:  Michael T Lewis; Jacqueline M Veltmaat
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

2.  Cooperative requirement of the Gli proteins in neurogenesis.

Authors:  Vân Nguyen; Ann L Chokas; Barbara Stecca; Ariel Ruiz i Altaba
Journal:  Development       Date:  2005-07       Impact factor: 6.868

3.  Asymmetric activation of Dll4-Notch signaling by Foxn4 and proneural factors activates BMP/TGFβ signaling to specify V2b interneurons in the spinal cord.

Authors:  Kamana Misra; Huijun Luo; Shengguo Li; Michael Matise; Mengqing Xiang
Journal:  Development       Date:  2013-11-20       Impact factor: 6.868

Review 4.  Molecular signaling pathways that regulate prostate gland development.

Authors:  Gail S Prins; Oliver Putz
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

5.  A novel Gli3 enhancer controls the Gli3 spatiotemporal expression pattern through a TALE homeodomain protein binding site.

Authors:  Sarah Coy; Jorge H Caamaño; Jaime Carvajal; Michael L Cleary; Anne-Gaëlle Borycki
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

Review 6.  LncRNAs: macromolecules with big roles in neurobiology and neurological diseases.

Authors:  Ye Chen; Jun Zhou
Journal:  Metab Brain Dis       Date:  2017-02-04       Impact factor: 3.584

Review 7.  The primary cilium at the crossroads of mammalian hedgehog signaling.

Authors:  Sunny Y Wong; Jeremy F Reiter
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

8.  Gain-of-function Shh mutants activate Smo cell-autonomously independent of Ptch1/2 function.

Authors:  Catalina Casillas; Henk Roelink
Journal:  Mech Dev       Date:  2018-08-23       Impact factor: 1.882

9.  Sonic hedgehog-patched Gli signaling in the developing rat prostate gland: lobe-specific suppression by neonatal estrogens reduces ductal growth and branching.

Authors:  Yongbing Pu; Liwei Huang; Gail S Prins
Journal:  Dev Biol       Date:  2004-09-15       Impact factor: 3.582

10.  Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation.

Authors:  Tim R Mercer; Irfan A Qureshi; Solen Gokhan; Marcel E Dinger; Guangyu Li; John S Mattick; Mark F Mehler
Journal:  BMC Neurosci       Date:  2010-02-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.